AUA 2012 Video Coverage

More AUA 2012 Coverage

Baldness Increases PCa Risk

Androgenic alopecia, also known as male pattern baldness, is significantly associated with an elevated risk for prostate cancer (PCa).

New Assay Identifies Men Who May Be at Lower Risk for PCa Recurrence After Surgery

A recently approved diagnostic assay may improve clinicians' ability to predict a prostate cancer patient's risk of clinical recurrence after radical prostatectomy (RP), a company announced at the American Urological Association 2012 annual meeting.

Oral Drug Prolongs Survival in Men with Late-Stage PCa

Enzalutamide, an investigational oral medication formerly known as MDV3100, prolongs survival by nearly five months in men with late-stage prostate cancer previously treated with docetaxel, according to data presented at the American Urological Association 2012 annual meeting.

Healthy Diet May Protect Against LUTS

Healthy eating may lower the risk of lower urinary tract symptoms (LUTS), according to data presented at the American Urological Association 2012 annual meeting.

Fesoterodine Relieves Nocturnal Urgency in OAB Patients

Flexible-dose fesoterodine is superior to placebo in decreasing the number of nocturnal urgency episodes and nocturnal micturitions in patients with overactive bladder (OAB), researchers reported at the American Urological Association 2012 annual meeting.

OAB Patients Most Bothered by Urgency

Patients with overactive bladder (OAB) say they are most bothered by symptoms of urinary urgency either as a primary complaint or as a driving symptom for frequency, according to a pilot study presented at the American Urological Association 2012 annual meeting.

BoNTA Safe, Effective for Diabetic OAB Patients

Diabetes has no influence on intravesical botulinum toxin type A (BoNTA) injection in overactive bladder (OAB) patients, researchers reported at the American Urological Association 2012 annual meeting.

Intermittent ADT May Offer Survival Edge in Advanced Prostate Cancer

Intermittent androgen deprivation (IAD) therapy is associated with improved all-cause and prostate cancer (PCa)-specific mortality among elderly patients with advanced PCa, according to data presented at the American Urological Association 2012 annual meeting.

Novel Catheter May Prevent Patient Injuries

Researchers have developed a novel catheter that they say can cut down on the number of catheter-related injuries, according to a presentation at the American Urological Association 2012 annual meeting.

Pyuria, Microhematuria Duration After Prostate Surgery Quantified

Pyuria persists longer than microhematuria after prostatic surgery and it is significantly associated with resected prostate weight, according to a study presented at the American Urological Association 2012 annual meeting.

Durable Oncologic Outcomes Reported for RARP

Robotic-assisted radical prostatectomy (RARP) is associated with long-term biochemical relapse-free survival, according to a study presented at the American Urological Association 2012 annual meeting.

Women More Likely to Die from Bladder Cancer

Women are more likely than men to have advanced bladder cancer disease found at the time of radical cystectomy and to die from the cancer, according to researchers at the American Urological Association 2012 annual meeting.

UI Incidence Low After Image-Guided Radiation Therapy

Prostate cancer (PCa) patients undergoing image-guided radiation therapy (IGRT) experience a low incidence of treatment-related urinary incontinence (UI), researchers reported at the American Urological Association 2012 annual meeting.

Prolonged Surgical Delay Increases Bladder Cancer Recurrence Risk

A prolonged delay between bladder cancer diagnosis and cystectomy is associated with an increased risk of disease recurrence and mortality, according to a study presented at the American Urological Association 2012 annual meeting.

Renal, Urothelial Cancers Linked to Lower Kidney Function

Lower renal function is associated with an increased independent risk for renal and urothelial cancer, according to data presented at the American Urological Association 2012 annual meeting.

Sign Up for Free e-newsletters